MEETING AGENDA AND PUBLIC NOTIFICATION
Therapeutics Committee
November 6, 2009
9:00 A.M.
Conference Center Room "C"
Indiana State Government Center South
- Call to Order-Chair
- Opening Comments-OMPP
- Approval of Memoranda, Meetings of August 7, 2009
- Preferred Drug List: Therapeutic Class Re-Review
- CNS and Others
- Antiemetics
- COX-II Inhibitors
- Narcotics
- Narcotic Antitussive/1st-generation Antihistamine Combinations
- NSAID/PPI Combination
- Skeletal Muscle Relaxants
- Smoking Deterrent Agents
- Dermatologic Agents
- Acne Agents
- Antipsoriatic Agents
- Endocrine
- Antidiabetic Agents, Oral
- Bone Resorption Inhibitors
- Forteo
- Growth Hormones
- Injectable Hypoglycemics
- Gastrointestinal Agents
- Chronic Constipation Agents
- H. Pylori Agents
- H2 Receptor Antagonists
- Pancreatic Enzymes
- Proton Pump Inhibitors
- Ulcerative Colitis Agents
- Genitourinary Agents
- Agents to Treat BPH
- Urinary Tract Antispasmodics
- Hematologic Agents
- Hematinics
- Heparin and Related Preparations
- Leukocyte (WBC) Stimulants
- Platelet Aggregation Inhibitors
- Topical Agents
- Eye Antihistamines, Mast Cell Stabilizers
- Glaucoma Agents
- Topical Anti-inflammatory, NSAIDS
- Topical Antiparasitics
- Topical Estrogen Agents
- Topical Immunomodulators
- Topical Post Herpetic Neuralgia Agents (Lidoderm)
- Wound Care Products
- Oral Contraceptives
- Prenatal Vitamins
- Synagis
- Xolair
- OTC Drug Formulary
- Smart PA Presentation
- Public Comment
- Other Business
- Adjourn
Posted by:
[FSSA]
« Back to Event List
Link to this event: